Moberg Pharma AB (MOB):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Moberg Pharma AB (MOB) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7855
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, is a pharmaceutical company. The company provides commercializes proprietary, acquired and licensed products. It provides treatment of skin diseases. Moberg Pharma treats fungal infection or psoriasis, discolored and fungus-damaged nails, Fast relief of pain and itch, Waterproof liquid bandage, minor skin irritations, diaper rash, skin irritation and rash and dry feet and cracked heels in one step. The company works in collaboration to develop Oral mucositis for the treatment of pain in the oral cavity. It offers licencing in and licencing out services. The company markets its products in Europe, South America, Africa, the Middle East and others. Moberg Pharma is headquartered in Stockholm, Sweden.

Moberg Pharma AB (MOB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Moberg Pharma AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Moberg Pharma AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Moberg Pharma AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Moberg Pharma AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Moberg Pharma AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Moberg Pharma AB, Medical Equipment, Deal Details 10
Equity Offering 10
Moberg Pharma to Raise USD16 Million in Private Placement of Shares 10
Moberg Pharma Raises USD8.6 Million in Private Placement of Shares 11
Moberg Pharma Completes Rights Offering Of Shares For US$5 Million 13
Moberg Pharma AB – Key Competitors 14
Moberg Pharma AB – Key Employees 15
Moberg Pharma AB – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Aug 07, 2018: Moberg Pharma interim report January – June 2018 17
May 08, 2018: Moberg Pharma Interim report January – March 2018 19
Feb 13, 2018: Moberg Pharma Year-end Report 2017 21
Nov 13, 2017: Moberg Pharma interim report January – September 2017 23
Aug 08, 2017: Moberg Pharma: interim report January- June 2017 24
May 09, 2017: Moberg Pharma interim report January – March 2017 26
Feb 14, 2017: Moberg Pharma Year-end report 2016 27
Corporate Communications 29
Aug 13, 2018: Moberg Pharma appoints new chief medical officer 29
Jun 20, 2018: Addition to Moberg Pharma’s management team 30
Apr 19, 2018: Moberg Pharma Announces Resignation Of Kjell Rensfeldt As VP Research and Development 31
Sep 22, 2017: Addition to Moberg Pharma´s management team 32
Product News 33
Jan 18, 2017: Moberg Pharma Expands New Skin Retail Presence 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Moberg Pharma AB, Medical Equipment, Key Facts, 2017 2
Moberg Pharma AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Moberg Pharma AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Moberg Pharma AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Moberg Pharma AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Moberg Pharma AB, Deals By Market, 2012 to YTD 2018 8
Moberg Pharma AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Moberg Pharma to Raise USD16 Million in Private Placement of Shares 10
Moberg Pharma Raises USD8.6 Million in Private Placement of Shares 11
Moberg Pharma Completes Rights Offering Of Shares For US$5 Million 13
Moberg Pharma AB, Key Competitors 14
Moberg Pharma AB, Key Employees 15
Moberg Pharma AB, Subsidiaries 16

List of Figures
Moberg Pharma AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Moberg Pharma AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Moberg Pharma AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Moberg Pharma AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Moberg Pharma AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Moberg Pharma AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Moberg Pharma AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Moberg Pharma AB, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Moberg Pharma AB (MOB):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dr. Paul Lohmann GmbH & Co KGaA:企業の戦略・SWOT・財務分析
    Dr. Paul Lohmann GmbH & Co KGaA - Strategy, SWOT and Corporate Finance Report Summary Dr. Paul Lohmann GmbH & Co KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Swadeshi Industrial Works Plc:企業の戦略・SWOT・財務情報
    Swadeshi Industrial Works Plc - Strategy, SWOT and Corporate Finance Report Summary Swadeshi Industrial Works Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sohar Aluminium LLC:企業の戦略・SWOT・財務情報
    Sohar Aluminium LLC - Strategy, SWOT and Corporate Finance Report Summary Sohar Aluminium LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Melkior Resources Inc. (MKR):企業の財務・戦略的SWOT分析
    Melkior Resources Inc. (MKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The Medicines Company (MDCO)-医療機器分野:企業M&A・提携分析
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products, namely, Angiomax (bivalirudin), Orbactiv (oritavancin), Minocin (minocycl …
  • Synthon Holdings BV-製薬・医療分野:企業M&A・提携分析
    Summary Synthon Holdings BV (Synthon) is an integrated pharmaceutical company which focuses on delivering affordable medicines through innovative science. The company undertakes the research, development, manufacture and distribution of generics, active pharmaceutical ingredients and biopharmaceutic …
  • Imperial Oil Limited:企業の戦略・SWOT・財務分析
    Imperial Oil Limited - Strategy, SWOT and Corporate Finance Report Summary Imperial Oil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Chembond Chemicals Ltd (530871):企業の財務・戦略的SWOT分析
    Chembond Chemicals Ltd (530871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • MetaStat Inc (MTST):製薬・医療:M&Aディール及び事業提携情報
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • Itamar Medical Ltd (ITMR):企業の財務・戦略的SWOT分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, manufactures, and markets non-invasive medical devices for the diagnosis of cardiology disease and sleep related breathing disorders. The company develops products using its proprietary peripheral arterial tonomet …
  • TH Heavy Engineering Berhad (THHEAVY):企業の財務・戦略的SWOT分析
    TH Heavy Engineering Berhad (THHEAVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Rekah Pharmaceutical Industry Ltd (REKA):企業の財務・戦略的SWOT分析
    Rekah Pharmaceutical Industry Ltd (REKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Dis-Chem Pharmacies Limited (DCP):企業の財務・戦略的SWOT分析
    Dis-Chem Pharmacies Limited (DCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Resverlogix Corp (RVX)-製薬・医療分野:企業M&A・提携分析
    Summary Resverlogix Corp (Resverlogix) is an epigenetics company that develops small molecule therapeutics for Bromodomain and ExtraTerminal Domain (BET) inhibition. The company provides lead product such as RVX-208 (apabetalone), is a BET inhibitor under phase III clinical trial. Its RVX-208 is bei …
  • Nightstar Therapeutics PLC (NITE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nightstar Therapeutics PLC (Nightstar Therapeutics), formerly Nightstar Therapeutics Ltd, is a clinical-stage gene therapy company. The company focus on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases. Its lead product cand …
  • Strike Energy Ltd (STX):石油・ガス:M&Aディール及び事業提携情報
    Summary Strike Energy Ltd (Strike Energy) is an oil and gas exploration and development company that explores, produces, and develops shale oil and gas. The company provides properties such as Eagle Ford Shale, Permian Basin, Cooper Basin, gulf coast conventional, and others. It has exploration and …
  • Navistar International Corporation (NAV):企業の財務・戦略的SWOT分析
    Navistar International Corporation (NAV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Earthstone Energy Inc (ESTE):石油・ガス:M&Aディール及び事業提携情報
    Summary Earthstone Energy Inc (Earthstone Energy), formerly Basic Earth Science Systems Inc is an independent oil and gas company that offers acquisition, exploration, production and development of oil and gas properties. The company's activities include acquiring, drilling, developing and producing …
  • Amdocs Limited:企業の戦略・SWOT・財務情報
    Amdocs Limited - Strategy, SWOT and Corporate Finance Report Summary Amdocs Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Herman Miller, Inc.:企業の戦略・SWOT・財務分析
    Herman Miller, Inc. - Strategy, SWOT and Corporate Finance Report Summary Herman Miller, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆